BRIEF published on 10/29/2025 at 09:50, 7 months 4 days ago Evotec SE to Release Q3 2025 Financial Results on November 5th Financial Results Conference Call Life Sciences Evotec SE 2025 Performance
PRESS RELEASE published on 10/29/2025 at 09:45, 7 months 4 days ago Evotec SE to announce results for the first nine months 2025 on 05 November 2025 Evotec SE to announce results for the first nine months 2025 on 05 November 2025. The Company will hold a conference call in English to discuss the interim statement Conference Call Financial Report Evotec SE Results Interim Statement
BRIEF published on 10/27/2025 at 07:35, 7 months 6 days ago Evotec Advances in Neuroscience Partnership with Bristol Myers Squibb Partnership Neuroscience Evotec Bristol Myers Squibb Neurodegenerative
PRESS RELEASE published on 10/27/2025 at 07:30, 7 months 6 days ago Evotec announces progress in preclinical neuroscience partnership with Bristol Myers Squibb Evotec SE announces US$ 25 m payment from Bristol Myers Squibb for progress in preclinical neuroscience partnership, advancing research on neurodegenerative diseases Partnership Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Research Progress
BRIEF published on 08/13/2025 at 07:05, 9 months 20 days ago Evotec SE Reports H1 2025 Results Highlighting Strategic Progress Financial Performance Evotec SE Strategic Growth Biologics Development H1 2025 Results
PRESS RELEASE published on 08/13/2025 at 07:00, 9 months 20 days ago Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE reports strong progress on strategy execution with H1 2025 results, showcasing sustainable profitable growth and key collaborations with BMS and Sandoz Evotec SE Growth Collaborations Strategy Execution H1 2025 Results
BRIEF published on 08/06/2025 at 09:57, 9 months 27 days ago Evotec SE to Release First Half-Year Results 2025 Conference Call Drug Discovery Life Sciences Evotec SE Half-year Results
PRESS RELEASE published on 08/06/2025 at 09:52, 9 months 27 days ago Evotec SE to announce first half-year results 2025 on 13 August 2025 Evotec SE to announce first half-year results for 2025 on 13 August 2025 with a conference call to discuss performance. Company focuses on drug discovery and development Conference Call Drug Discovery Evotec SE Half-year Results AI-driven Innovation
BRIEF published on 07/30/2025 at 07:21, 10 months 3 days ago Evotec and Sandoz Advance Partnership with Potential Toulouse Site Sale Strategic Partnership Evotec SE Biologics Manufacturing Sandoz AG Asset-Lighter Model
BRIEF published on 07/30/2025 at 07:19, 10 months 3 days ago Evotec SE and Sandoz AG to Potentially Sell Just – Evotec Biologics Toulouse Site Evotec SE Transaction Terms Sandoz AG Biologics Sale Toulouse Site
Published on 06/02/2026 at 14:30, 25 minutes ago AIAI Holdings and Constellation Network Launch Arca Wallet, a Wallet to Self-Manage Digital Dollars
Published on 06/02/2026 at 14:00, 55 minutes ago Critical Elements Announces Participation in THE Mining Investment Event, Quebec City, June 2-4, 2026
Published on 06/02/2026 at 13:35, 1 hour 20 minutes ago Silver X Intersects 40.71 m True Width at 98.7 g/t AgEq (69.53 g/t Ag, 0.87% Pb, 0.28% Zn) at Blenda Rubia, Including 4.12 m of 274.5 g/t AgEq
Published on 06/02/2026 at 13:00, 1 hour 55 minutes ago Uraniumx Reports Visually Identified Pitchblende At Murphy Lake
Published on 06/02/2026 at 13:00, 1 hour 55 minutes ago AI/ML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
Published on 06/02/2026 at 14:30, 24 minutes ago DAMAC Digital reaches 6,000MW planned IT capacity landbank across North America, Europe, Asia, and the Middle East
Published on 06/02/2026 at 14:00, 55 minutes ago Shelly Group Consistently Aligns Global Marketing Organization with Next Phase of International Scaling
Published on 06/02/2026 at 13:40, 1 hour 14 minutes ago From Mind to Hand: TARS Brings a Dexterous Hand with Brain and AWE3.0 to ICRA 2026
Published on 06/02/2026 at 13:39, 1 hour 16 minutes ago EQS-Adhoc: K+S Aktiengesellschaft: K+S acquires Qemetica's salt business in Poland and Germany (2025 EBITDA: ~EUR 50m); Purchase price between EUR 350m and EUR 380m, depending on performance (Multiple: ~7x)
Published on 06/02/2026 at 08:00, 6 hours 55 minutes ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 07:30, 7 hours 25 minutes ago OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest
Published on 06/02/2026 at 07:00, 7 hours 55 minutes ago BIOPHYTIS STRATEGIC UPDATE: JOINT VENTURE REGISTRATION FILING SUBMITTED IN HONG KONG
Published on 06/01/2026 at 18:47, 20 hours 7 minutes ago Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 20 hours 55 minutes ago Covivio - Information on total number of voting rights and share capital
